Furthermore, a noteworthy observation was made as pretreatment of various prostate cancer cells with docetaxel resulted in increased RRM2 expression.This gene’s potential regulatory influence on drug resistance appears to involve the activation of the AKT signaling pathway. This evidence concerns the gene RRM2 and prostate carcinoma.